Axogen: Sales Sprint Ahead; Profitability Takes a Breather
Axogen reported that sales of its innovative nerve repair products generated $70 million for the June quarter, up a very respectable 13%.
Useful takeaways from this story.
Axogen reported that sales of its innovative nerve repair products generated $70 million for the June quarter, up a very respectable 13%.
Building the complete brief
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
The useful part
Axogen reported that sales of its innovative nerve repair products generated $70 million for the June quarter, up a very respectable 13%.
Keep reading in the app
Open the app view to save this story, compare related coverage, and continue from the same source.